SCHEMBL22086181

SCHEMBL22086181

Cc1cc(-c2cn(-c3ccccc3)c3c(=O)[nH]cnc23)ccn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.50
MAPT P10636 6/20 0.48
LMNA P02545 3/20 0.48
KMT2A Q03164 1/20 0.48
HTT P42858 1/20 0.48
BRD4 O60885 2/20 0.46
PKM P14618 1/20 0.43
GAA P10253 1/20 0.43
GRM2 Q14416 1/20 0.41
CCNC P24863 2/20 0.39
CDK8 P49336 2/20 0.39
PDPK1 O15530 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
CDC7 O00311 1/20 0.38
ROCK2 O75116 1/20 0.38
MAP4K4 O95819 1/20 0.38
CDK2 P24941 1/20 0.38
GSK3B P49841 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22084892 0.86 MAPT (0.46) SRCMAPTLMNAKMT2AHTT
SCHEMBL22032007 0.84 SRC (0.55) SRCMAPTLMNAKMT2AHTT
SCHEMBL8819526 0.84 SRC (0.64) SRCMAPTLMNAKMT2AHTT
SCHEMBL22086190 0.83 BRD4 (0.50) SRCMAPTLMNAKMT2AHTT
SCHEMBL22086425 0.81 SRC (0.49) SRCMAPTLMNAKMT2AHTT
SCHEMBL22084719 0.81 SRC (0.49) SRCMAPTLMNAKMT2AHTT
SCHEMBL22084725 0.81 SRC (0.48) SRCMAPTLMNAKMT2AHTT
SCHEMBL20912335 0.80 SRC (0.49) SRCMAPTLMNAKMT2AHTT
SCHEMBL20898225 0.80 SRC (0.50) SRCMAPTLMNAKMT2AHTT
SCHEMBL22086423 0.80 SRC (0.47) SRCMAPTLMNAKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230055250-A1 MAP4K4 INHIBITORS IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2023-02-23 US disclosed
WO-2020115481-A1 MAP4K4 INHIBITORS IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE (GB) 2020-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230055250-A1 MAP4K4 INHIBITORS MAP4K4, MAP4K5, MAP4K1 SRC 739/4885MAPT 261/4885LMNA 2539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.